Simulations Plus, Inc. (NASDAQ:SLP) major shareholder Walter S. Woltosz sold 18,500 shares of the stock in a transaction that occurred on Wednesday, September 27th. The stock was sold at an average price of $15.45, for a total value of $285,825.00. Following the completion of the transaction, the insider now directly owns 5,647,916 shares of the company’s stock, valued at approximately $87,260,302.20. The sale was disclosed in a filing with the SEC, which is accessible through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Simulations Plus, Inc. (NASDAQ:SLP) traded down 0.64% on Friday, reaching $15.50. The company had a trading volume of 35,814 shares. Simulations Plus, Inc. has a 52 week low of $8.10 and a 52 week high of $16.15. The stock’s 50-day moving average is $14.56 and its 200-day moving average is $12.70. The company has a market capitalization of $267.30 million, a P/E ratio of 49.21 and a beta of -0.71.

Simulations Plus (NASDAQ:SLP) last posted its earnings results on Friday, July 14th. The technology company reported $0.13 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.02. The company had revenue of $6.75 million during the quarter, compared to analyst estimates of $6.48 million. Simulations Plus had a return on equity of 23.21% and a net margin of 24.86%. Equities research analysts forecast that Simulations Plus, Inc. will post $0.32 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece was published by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at https://www.watchlistnews.com/simulations-plus-inc-slp-major-shareholder-walter-s-woltosz-sells-18500-shares-of-stock/1599313.html.

Several research analysts have recently issued reports on the company. Zacks Investment Research raised Simulations Plus from a “sell” rating to a “hold” rating in a research report on Tuesday, June 27th. BidaskClub lowered Simulations Plus from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st.

Institutional investors have recently bought and sold shares of the business. The Manufacturers Life Insurance Company lifted its holdings in Simulations Plus by 13.8% during the second quarter. The Manufacturers Life Insurance Company now owns 8,923 shares of the technology company’s stock worth $110,000 after buying an additional 1,085 shares during the period. OxFORD Asset Management LLP purchased a new stake in Simulations Plus during the second quarter worth $126,000. Rhumbline Advisers purchased a new stake in Simulations Plus during the second quarter worth $126,000. New York State Common Retirement Fund purchased a new stake in Simulations Plus during the second quarter worth $143,000. Finally, KCG Holdings Inc. purchased a new stake in Simulations Plus during the first quarter worth $152,000. Institutional investors own 32.01% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.

Insider Buying and Selling by Quarter for Simulations Plus (NASDAQ:SLP)

Receive News & Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.